HEPARIN IN THE TREATMENT OF PULMONARY THROMBO-EMBOLISMKANIS JA.1974; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1974; VOL. 32; NO 2-3; PP. 519-527; ABS. FR. ALLEM.; BIBL. 15REF.Article

MIXED SCLEROSING BONE DYSTROPHY WITH REGRESSION OF MELORHEOSTOSIS = DYSTROPHIE OSSEUSE CONDENSANTE MIXTE AVEC REGRESSION DE LA MELORHEOSTOSEKANIS JA; THOMSON JG.1975; BRIT. J. RADIOL.; G.B.; DA. 1975; VOL. 48; NO 569; PP. 400-402; BIBL. 11REF.Article

TREATMENT OF PAGET'S DISEASE OF BONE WITH PORCINE CALCITONIN: CLINICAL AND METABOLIC RESPONSES. = TRAITEMENT DE LA MALADIE DE PAGET DE L'OS AVEC DE LA CALCITONINE DE PORC. REPONSES CLINIQUES ET METABOLIQUESKANIS JA; FITZPATRICK K; STRONG JA et al.1975; QUART. J. MED.; G.B.; DA. 1975; VOL. 44; NO 175; PP. 399-413; BIBL. 23 REF.Article

EFFECT OF BROMOCRIPTINE ON PLASMA GROWTH HORMONE AND GLUCOSE TOLERANCE IN CHRONIC RENAL FAILUREKANIS JA; LEDINGHAM JGG; OLIVER DO et al.1976; BRIT. MED. J.; G.B.; DA. 1976; NO 6014; PP. 879; BIBL. 4 REF.Article

PLASMA CALCITONIN IN PAGET'S DISEASE OF BONE.KANIS JA; HEYNEN G; WALTON RJ et al.1977; CLIN. SCI. MOLEC. MED.; G.B.; DA. 1977; VOL. 52; NO 3; PP. 329-332; BIBL. 20 REF.Article

PATHOPHYSIOLOGY AND TREATMENT OF OSTEOMALACIA IN RENAL FAILUREKANIS JA; PATERSON A; CAMERON EC et al.1981; DIAL. TRANSPLANT.; ISSN 0090-2934; USA; DA. 1981; VOL. 10; NO 6; PP. 490-508; 11 P.; BIBL. 81 REF.Article

AN ESTIMATE OF THE TURNOVER RATE OF BONE-DERIVED PLASMA ALKALINE PHOSPHATASE IN PAGET'S DISEASE. = ESTIMATION DU TAUX DE RENOUVELLEMENT DE LA PHOSPHATASE ALCALINE DU PLASMA D'ORIGINE OSSEUSE DANS LA MALADIE DE PAGETWALTON RJ; PRESTON CJ; RUSSELL RGG et al.1975; CLIN. CHIM. ACTA; PAYS-BAS; DA. 1975; VOL. 63; NO 2; PP. 227-229; BIBL. 6 REF.Article

VARIATIONS DES TAUX SERIQUES DE PARATHORMONE AU COURS DU TRAITEMENT DE LA MALADIE DE PAGET PAR CALCITONINE HUMAINE OU DE SAUMONHEYNEN G; FRANCHIMONT P; GASPAR S et al.1981; ANN. ENDOCRINOL.; ISSN 0003-4266; FRA; DA. 1981; VOL. 42; NO 3; PP. 265-275; ABS. ENG; BIBL. 26 REF.Article

EVIDENCE THAT ENDOGENOUS CALCITONIN PROTECTS AGAINST RENAL BONE DISEASE.HEYNEN G; KANIS JA; OLIVER D et al.1976; LANCET; G.B.; DA. 1976; NO 7999; PP. 1322-1326; BIBL. 26 REF.Article

THE ABSENCE OF 24,25-DIHYDROXYCHOLECALCIFEROL IN ANEPHRIC PATIENTSTAYLOR CM; MAWER EB; WALLACE JE et al.1978; CLIN. SCI. MOLEC. MED.; GBR; DA. 1978; VOL. 55; NO 6; PP. 541-547; BIBL. 20 REF.Article

MEASUREMENT OF WHOLE BODY CALCIUM IN CHRONIC RENAL FAILURE: EFFECTS OF 1ALPHA -HYDROXYVITAMIN D₃ AND PARATHYROIDECTOMY.NAIK RB; DABEK JT; HEYNEN G et al.1977; CLIN. ENDOCRINOL.; G.B.; DA. 1977; VOL. 7; SUPPL.; PP. 139S-145S; BIBL. 11 REF.Article

DETERIORATION OF RENAL BONE DISEASE IN PATIENTS TREATED WITH SALMON CALCITONINCUNDY T; KANIS JA; HEYNEN G et al.1982; CLIN. ENDOCRINOL. (OXF.); ISSN 0300-0664; GBR; DA. 1982; VOL. 16; NO 1; PP. 29-37; BIBL. 18 REF.Article

LA CALCITONINE SERIQUE DANS LA CIRRHOSE ETHYLIQUELUISETTO G; HEYNEN G; CECHETTIN M et al.1978; ACTA CLIN. BELG.; BEL; DA. 1978; VOL. 33; NO 5; PP. 296-302; ABS. ENG/DUT; BIBL. 18 REF.Article

FACTORS INFLUENCING THE RESPONSE TO 1ALPHA -HYDROXYVITAMIN D₃ IN PATIENTS WITH RENAL BONE DISEASE.KANIS JA; RUSSELL RGG; NAIK RB et al.1977; CLIN. ENDOCRINOL.; G.B.; DA. 1977; VOL. 7; SUPPL.; PP. 51S-57S; BIBL. 9 REF.Article

CALCIUM METABOLISM IN SUBJECTS LIVING WITH A PERMANENT ILEOSTOMYKENNEDY HJ; COMPSTON J; HEYNEN G et al.1983; DIGESTION; ISSN 0012-2823; CHE; DA. 1983; VOL. 26; NO 3; PP. 131-136; BIBL. 18 REF.Article

SERIAL ASSAYS OF PLASMA GROWTH HORMONE IN TREATED AND UNTREATED ACROMEGALY = DOSAGES EN SERIE DE L'HORMONE SOMATOTROPE PLASMATIQUE CHEZ DES ACROMEGALES TRAITES ET NON TRAITESHUNTER WM; GILLINGHAM FJ; HARRIS P et al.1974; J. ENDOCRINOL.; G.B.; DA. 1974; VOL. 63; NO 1; PP. 21-34; BIBL. 21REF.Article

EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCEMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEDOUGLAS DL; RUSSEL RGG; PRESTON CJ et al.1980; LANCET; GBR; DA. 1980; NO 8177; PP. 1043-1047; BIBL. 20 REF.Article

IS 24,25-DIHYDROXYCHOLECALCIFEROL A CALCIUM-REGULATING HORMONE IN MAN .KANIS JA; CUNDY T; BARTLETT M et al.1978; BRIT. MED. J.; G.B.; DA. 1978; NO 6124; PP. 1382-1386; BIBL. 39 REF.Article

CHANGES IN HISTOLOGIC AND BIOCHEMICAL INDEXES OF BONE TURNOVER AFTER BILATERAL NEPHRECTOMY IN PATIENTS ON HEMODIALYSIS. EVIDENCE FOR POSSIBLE ROLE OF ENDOGENOUS CALCITONIN.KANIS JA; EARNSHAW M; HEYNEN G et al.1977; NEW ENGL. J. MED.; U.S.A.; DA. 1977; VOL. 296; NO 19; PP. 1073-1079; BIBL. 39 REF.Article

WHOLE-BODY IN-VIVO NEUTRON ACTIVATION ANALYSIS IN ASSESSING TREATMENT OF RENAL OSTEODYSTROPHY WITH I-ALPHA-HYDROXYCHOLECALCIFEROL.NAIK RB; GOSLING P; PRICE CP et al.1976; BRIT. MED. J.; G.B.; DA. 1976-07; PP. 79-83; BIBL. 31 REF.Article

LONG-TERM TREATMENT OF OSTEOPOROSIS WITH 24,25 DIHYDROXYCHOLECALCIFEROLREEVE J; TELLEZ M; GREEN JR et al.1982; ACTA ENDOCRINOL. (KBH); ISSN 0001-5598; DNK; DA. 1982; VOL. 101; NO 4; PP. 636-640; BIBL. 22 REF.Article